Use and impact of cardiac medication during pregnancy.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Future Cardiology

• Publication date

  2015-01-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.2217/fca.14.68PMID 25606705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac Drugs in Pregnancy

  2014cited by this paper
• 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

  2014cited by this paper
• 2013 ACC/AHA cholesterol treatment guideline: what was done well and what could be done better.

  2014cited by this paper
• Drug treatment of hypertension in pregnancy: a critical review of adult guideline recommendations

  2014cited by this paper
• Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology.

  2013cited by this paper
• Saving Mothers’ Lives: Reviewing Maternal Deaths to Make Motherhood Safer 2006-2008 A Review

  2012cited by this paper
• Patterns of Outpatient Antihypertensive Medication Use During Pregnancy in a Medicaid Population

  2012cited by this paper
• Fondaparinux - data on efficacy and safety in special situations.

  2012cited by this paper
• Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008

  2011cited by this paper
• ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC).

  2011cited by this paper
• How to manage hypertension in pregnancy effectively.

  2011cited by this paper
• Clinical Therapeutics in Pregnancy

  2011cited by this paper
• ESC Guidelines on the management of cardiovascular diseases during pregnancy

  2011cited by this paper
• Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants—but are we convinced? Evaluation of an apparently conclusive meta‐analysis with trial sequential analysis

  2011cited by this paper
• Antihypertensive drugs in pregnancy.

  2011cited by this paper
• Drugs in pregnancy: Implications for a cardiologist.

  2010cited by this paper
• Heart disease – why is maternal mortality increasing?

  2009cited by this paper
• The global impact of pre-eclampsia and eclampsia.

  2009cited by this paper
• Cardiac drug use in pregnancy: safety, effectiveness and obstetric implications

  2009cited by this paper
• Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.

  2008cited by this paper
• Trauma and surgical emergencies in the obstetric patient.

  2008cited by this paper
• Use of antihypertensive drugs during pregnancy and lactation.

  2008cited by this paper
• Drug-eluting stent implantation for acute myocardial infarction during pregnancy with use of glycoprotein IIb/IIIa inhibitor, aspirin and clopidogrel.

  2008cited by this paper
• Changes in Enoxaparin Pharmacokinetics During Pregnancy and Implications for Antithrombotic Therapeutic Strategy

  2008cited by this paper
• Aspirin and Reye Syndrome

  2007cited by this paper
• Pregnancy and adult congenital heart disease

  2007cited by this paper
• Risks of statin use during pregnancy: a systematic review.

  2007cited by this paper
• Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes.

  2007cited by this paper
• Outcome of pregnancy in women with congenital heart disease: a literature review.

  2007cited by this paper
• Aspirin and Reye syndrome: a review of the evidence.

  2007cited by this paper
• ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committ

  2006cited by this paper
• ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit

  2006cited by this paper
• Recommendations for the management of patients after heart valve surgery.

  2005cited by this paper
• Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy

  2004cited by this paper
• Safe anticoagulation with danaparoid in pregnancy and lactation

  2004cited by this paper
• Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations.

  2003cited by this paper
• ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing co

  2003cited by this paper
• Regional Anesthesia in the Anticoagulated Patient: Defining the Risks

  2003cited by this paper
• Maternal and fetal side effects of tocolysis using transdermal nitroglycerin or intravenous fenoterol combined with magnesium sulfate.

  2003cited by this paper
• Aspirin for Prevention of Preeclampsia in Women With Historical Risk Factors: A Systematic Review

  2003cited by this paper
• Regional Anesthesia in the Anticoagulated Patient: Defining the Risks (The Second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation)

  2003cited by this paper
• Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis.

  2002cited by this paper
• Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia.

  2002cited by this paper
• ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists.

  2002cited by this paper
• Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy.

  2002cited by this paper
• [Anticoagulant therapy during pregnancy in patients with mechanical valvular prostheses].

  2001cited by this paper
• ACOG practice bulletin

  2001cited by this paper
• The generalizability of trial data; a comparison of β-blocker trial participants with a prospective cohort of women taking β-blockers in pregnancy

  2001cited by this paper
• The generalizability of trial data; a comparison of beta-blocker trial participants with a prospective cohort of women taking beta-blockers in pregnancy.

  2001cited by this paper
• Drugs in pregnancy. Pharmacokinetics in pregnancy.

  2001cited by this paper
• Calcium channel blockers in the management of preterm labor and hypertension in pregnancy.

  2001cited by this paper
• Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis.

  2000cited by this paper
• A population-based case-control teratologic study of oral oxytetracycline treatment during pregnancy.

  2000cited by this paper
• Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves.

  1999cited by this paper
• Treatment of Cardiac Arrhythmias During Pregnancy

  1999cited by this paper
• Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre‐eclampsia and its complications

  1998cited by this paper
• Antiarrhythmic drug therapy in pregnancy and lactation.

  1998cited by this paper
• Small platelet thrombi contribute to neointimal formation in allograft vascular disease by bridging the inflammatory and smooth muscle cell responses

  1998cited by this paper
• Drugs in pregnancy.

  1998cited by this paper
• The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study.

  1996cited by this paper
• Use of flecainide for refractory atrial tachycardia of pregnancy.

  1996cited by this paper
• Propafenone in the Treatment of Cardiac Arrhythmias

  1995cited by this paper
• Labetalol vs. methyldopa in the treatment of pregnancy‐induced hypertension

  1995cited by this paper
• Maternal adaptation to pregnancy

  1995cited by this paper
• Maternal Cardiovascular Hemodynamic Adaptation to Pregnancy

  1994cited by this paper
• A longitudinal study of cardiac output in normal human pregnancy.

  1994cited by this paper
• Procainamide administration during pregnancy.

  1993cited by this paper
• Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone.

  1993cited by this paper
• Adaptation of the maternal heart in pregnancy

  1992cited by this paper
• Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia.

  1991cited by this paper
• Adenosine and supraventricular tachycardia.

  1991cited by this paper
• Coadministration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta, and excretion in human breast milk.

  1990cited by this paper
• Atenolol in essential hypertension during pregnancy.

  1990cited by this paper
• Beta-adrenergic blockers in pregnancy.

  1988cited by this paper
• Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk

  1986cited by this paper
• Supraventricular Tachycardia in Pregnancy: Cardioversion with Verapamil

  1984cited by this paper
• PHARMACOKINETICS IN PREGNANCY

  1981cited by this paper
• The Influence of Pregnancy upon Blood Coagulation and Plasma Fibrinolytic Enzyme Function

  1979cited by this paper

• Coronary microvascular dysfunction in pregnancy: time to pay closer attention?

  2026cites this paper
• Clinical case of a 29 weeks pregnant patient with ST-segment elevation myocardial infarction

  2023cites this paper
• In Utero Exposure to Antihypertensive Medication during the First Trimester: Is the Risk Worth Taking?

  2021cites this paper
• Cardiovascular and pregnancy outcomes in women with coronary microvascular dysfunction: a case series

  2019cites this paper
• Cardiac Drugs in Pregnancy

  2018cites this paper
• Pregnancy and Cardiac Disease.

  2017cites this paper
• Embarazo y enfermedad cardiaca

  2017cites this paper
• Organisation of care for pregnancy in patients with congenital heart disease

  2017cites this paper
• Manual Vacuum Aspiration (MVA) - A safe option for evacuation of first trimester miscarriage in cardiac patients.

  2017cites this paper
• Preeclampsia y defecto cardiaco fetal: ¿existe una asociación? Revisión de la evidencia

  2016cites this paper
• Managing cardiac emergencies in pregnancy

  2016cites this paper
• MANAGING PREGNANT CARDIAC PATIENTS IN A TERTIARY CARDIAC CARE UNIT IMPROVES FETOMATERNAL OUTCOME

  2015cites this paper
• Epidemiology of medications use in pregnancy.

  2015cites this paper